Biosimilars for Research through Development

Robust analytical testing, thorough biophysical characterization, and a cost-effective strategy to scale up are the keys to accelerating the development of biosimilars. We are the only trusted industry partner that combines comprehensive technologies and the regulatory know-how to help you make the transition from developing novel biologics to introducing and developing biosimilars, biobetters, and bioexacts.

 
Biosimilars Immunogenecity Assessment
Biophysical Characterization
Broad array of analytical technology platforms & tools to assess biochemical, biophysical and physiological attributes of biosimilars

SILuMAb
ADC mimics
SOLu-trypsin
BIOshell
Chromolith

 

 
Biosimilars Biophysical Characterization
Immunogenicity Assessment
State-of-the art instruments & assays to accurately predict the immunogenic potential of biosimilars


Milliplex assays
Singulex assays
Amnis® Protein Aggregate Detection Kit


 

 
Biosimilars Upstream Process Development
Upstream Process Development
Cell line development platforms, scale up/ manufacturing solutions & regulatory services to speed up your biosimilar drug development

CC Media
CHOZN Platform
Emprove
Bioreliance - End to end service &
  Validation Testing

 


 Learning Center